MYCELX Technologies Corporation
MYX.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | £2 | £1 | £4 | £5 |
| % Growth | 19% | -59.9% | -34.4% | – |
| Cost of Goods Sold | £1 | £1 | £3 | £4 |
| Gross Profit | £1 | £0 | £1 | £1 |
| % Margin | 41.7% | 25.5% | 28.2% | 25.7% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £3 | £3 | £3 | £3 |
| SG&A Expenses | £3 | £3 | £3 | £3 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £0 | £0 | £0 | £0 |
| Operating Expenses | £3 | £3 | £3 | £3 |
| Operating Income | -£2 | -£2 | -£2 | -£2 |
| % Margin | -123.8% | -173% | -60.7% | -37.8% |
| Other Income/Exp. Net | £0 | £1 | £1 | -£0 |
| Pre-Tax Income | -£2 | -£1 | -£1 | -£2 |
| Tax Expense | £0 | £0 | £0 | £0 |
| Net Income | -£2 | -£1 | -£1 | -£2 |
| % Margin | -114.7% | -97.1% | -38.9% | -41.2% |
| EPS | -0.079 | -0.06 | -0.06 | -0.096 |
| % Growth | -31% | 0% | 37.4% | – |
| EPS Diluted | -0.08 | -0.06 | -0.059 | -0.096 |
| Weighted Avg Shares Out | 24 | 23 | 23 | 23 |
| Weighted Avg Shares Out Dil | 24 | 24 | 23 | 23 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £0 | £0 | £0 | £0 |
| EBITDA | -£2 | -£2 | -£2 | -£2 |
| % Margin | -114.5% | -161.4% | -54% | -29.8% |